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Abstract
Background—Maternal nutritional status has been evaluated to clarify its role in development
of neural tube defects (NTDs). Maternal folate intake during pregnancy has been closely evaluated
for its association with NTDs.
Objective—The study objective was to examine associations between NTDs and other dietary
periconceptional micronutrient intake, particularly nutrients involved in one-carbon metabolism or
antioxidant activity.
Design—Using data from the National Birth Defects Prevention Study, 1997–2005, logistic
regression models were used to estimate the relative risk of NTDs based on maternal
micronutrient intake.
Results—Results were stratified according to folic acid supplement use, race/ethnicity, and
maternal body mass index. Analyses included 954 cases (300 with anencephaly, 654 with spina
bifida) and 6268 controls. Higher intakes of folate, thiamin, betaine, iron, and vitamin A were
associated with decreased risk of anencephaly among some ethnic and clinical groups. In some
groups, higher intakes of thiamin, riboflavin, vitamin B6, vitamin C, vitamin E, niacin, and retinol
were associated with decreased risk of spina bifida.
Conclusion—In addition to folic acid, other micronutrients, including thiamin, betaine,
riboflavin, vitamin B6, vitamin C, vitamin E, niacin, iron, retinol, and vitamin A, may decrease the
risk of NTD occurrence.
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INTRODUCTION
The neural tube is closed by 28 days post-conception. Incomplete closure of the neural tube,
most commonly results in anencephaly or spina bifida (Sadler, 2005). Maternal nutritional
status has been evaluated to clarify its role in development of neural tube defects (NTDs). It
is well-established that increased periconceptional folic acid intake reduces a woman’s risk
of a NTD-affected pregnancy (1991; Berry and others, 1999; Boulet and others, 2008;
Canfield and others, 2005; Czeizel and Dudas, 1992; Williams and others, 2005). Studies
have also investigated other nutrients that may be involved in the etiologies of NTDs,
though the evidence for other nutrients is substantially less (Mills and others, 1992; Ray and
others, 2007; Shaw and others, 2004; Shaw and others, 1997; Suarez and others, 2003; Velie
and others, 1999; Wang and others, 2010).
Folate is vital to convert homocysteine to methionine and facilitate deoxyribonucleic acid
methylation and synthesis (Stover, 2009). Riboflavin, vitamin B6, vitamin B12, choline,
betaine and zinc are additional enzyme cofactors or methyl-donors in folate one-carbon
metabolism (Benevenga, 2007; Mason, 2003; Standing Committee on the Scientific
Evaluation of Dietary Reference Intakes, 1998). Lack of these cofactors may result in
increased levels of homocysteine, and maternal hyperhomocysteinemia has been associated
with elevated NTD risk (Mills and others, 1995; Steegers-Theunissen and others, 1994;
Zhao and others, 2006). Several studies demonstrate that increased maternal intake of
methionine (Graham and others, 2010; Shaw and others, 1997), choline (Shaw and others,
2004), betaine (Benevenga, 2007; Shaw and others, 2004; Zhu and others, 2005), vitamin
B12 (Mills and others, 1992; Ray and others, 2007; Suarez and others, 2003; Wang and
others, 2010) and zinc (Velie and others, 1999) may decrease the risk of NTDs.
Additionally, oxidative stress has been implicated in increasing NTD risk (Chang and
others, 2003; Zhao and others, 2006). Maternal diabetes is a known state of oxidative stress
and has long been associated with increased birth defect risks, particularly NTDs and
congenital heart disease (Correa and others, 2008). Micronutrients with antioxidant capacity
such as vitamins C and E may reduce NTD risk (Loeken, 2004). Lower vitamin C serum
levels have been reported in women with histories of NTD-affected pregnancies (Smithells
and others, 1976).
Other nutrients such as vitamin A, retinol, iron, and zinc occasionally are included in the
oxidative pathway but have complex involvement in many biological systems. Similarly,
niacin is often studied with other B vitamins but is not directly related to one-carbon
metabolism.
The previously published report by Mosley et al. (Mosley and others, 2009) for the National
Birth Defects Prevention Study (NBDPS) evaluated the association between maternal folate
intake and NTDs. The current analysis is the largest case-control study examining potential
associations between NTDs and dietary periconceptional intake of micronutrients involved
in one-carbon metabolism and antioxidant activity.
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The NBDPS, established 1997, is an ongoing, case-control study of birth defects being
conducted in the US. Participants were recruited from one of 10 population-based birth
defects surveillance systems. Study methods and descriptions of these programs have been
published (Yoon and others, 2001). Institutional Review Boards for participating Centers
approved the study along with the Centers for Disease Control and Prevention. All subjects
gave written informed consent. Participation rates for NBDPS approximate 62% for
anencephaly, 76% for spina bifida, and 71% for controls.
Data from case and control women with pregnancies from 1997 to 2005 are included in this
analysis. Case women had a pregnancy complicated by anencephaly or spina bifida, not
associated with a single gene disorder or chromosomal abnormality. NTD diagnoses were
verified by clinical geneticists based on information obtained from medical records. Control
women were randomly selected and had a pregnancy resulting in a live-born with no major
birth defect. Cases and controls spoke English or Spanish. Women who were incarcerated or
placed their infants into foster care or with adoptive parents were ineligible.
Inclusions and exclusions
A total of 1,082 cases and 6,807 controls were evaluated for eligibility. Mothers with
pregnancies resulting in multiple births were excluded (49 cases, 168 controls). Women with
preexisting type 1 or 2 diabetes mellitus were excluded (15 cases, 42 controls). Women who
reported periconceptional use of folate antagonist medication, including dilantin, valproic
acid, sodium valproate, carbamazepine, methotrexate, trimethoprim, trimethoprim
hydrochloride, trimethoprim sulfate, trimethoprim-sulfadiazine, and trimethoprim-
sulfamethoxazole were excluded (4 cases, 9 controls). Furthermore, participants who had
incomplete food frequency questionnaires (57 cases, 244 controls) or reported average daily
energy intake <500 or >5,000 kilocalories, suggesting their intakes were implausible, (21
cases, 159 controls) were also excluded. The current data analysis included 954 (88%) cases
and 6,268 (92%) controls.
Micronutrient intake
Telephone interviews were conducted between 6 weeks to 24 months after the estimated
date of delivery. Dietary intake for the year prior to pregnancy was recorded using a
modified Willett Food Frequency Questionnaire (Willett and others, 1987), which consists
of 58 food items. Additional questions were included in interviews regarding consumption
of breakfast cereals. Micronutrient intake values were obtained from Release 20 of the US
Department of Agriculture (USDA) National Nutrient Database for Standard Reference (US
Department of Agriculture and Agricultural Research Service, 2008b). For choline, nutrient
values were computed from the USDA Choline Database Release 2 (US Department of
Agriculture and Agricultural Research Service, 2008a). We limited analysis to the following
micronutrients: folate, methionine, cysteine, total choline, betaine, thiamin, riboflavin,
vitamin B6, vitamin B12, vitamin C, vitamin E, alanine, niacin, iron, zinc, retinol, and
vitamin A (RAE).
Periconceptional use of a multivitamin, prenatal vitamin or folic acid-only supplement was
documented in monthly intervals from 3 months before pregnancy until final month of
pregnancy. Supplement use was divided into 2 categories: women with any folic acid
supplement intake from 3 months before pregnancy through the first month of pregnancy
were “supplement users” and women with no folic acid supplement use during this time
were “non-users of supplements.”
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Dietary folate is a vitamin B9 form naturally occurring in food sources. Dietary folic acid is
the synthetic vitamin form used in food fortification. Because synthetic folic acid is more
readily bioavailable than naturally occurring dietary folate, the term dietary folate
equivalents (DFEs) refers to total dietary folate intake that accounts for the difference in
bioavailability of the two forms by multiplying the amount of dietary folic acid in fortified
foods by 1.7 and adding the amount of natural folate contained in foods (Standing
Committee on the Scientific Evaluation of Dietary Reference Intakes, 1998).
Intakes of micronutrients from foods were categorized by quartile based on distribution of
each micronutrient among controls. Women with micronutrient intakes less than 25th
percentile were used as the referent group. Among micronutrients when odds ratio (OR) for
3rd quartile compared to 1st quartile were statistically significant whereas OR for 4th quartile
compared to 1st quartile did not reach statistical significance, results were presented in the
table but not discussed in the text. These results were most likely due to sample size
limitations or random fluctuation.
Statistical analysis
Adjusted odds ratios with 95% confidence intervals (CI) were calculated using multiple
logistic regression to estimate risk associations between dietary micronutrient intake and
NTDs. Models included adjustments based on center and energy intake (quartiles). Results
were stratified by phenotype (anencephaly or spina bifida) and supplement use, race/
ethnicity, and maternal body mass index (BMI). Groupings for self-reported race/ethnicity
consisted of white, non-Hispanic; Hispanic; and black, non-Hispanic; mothers in other or
unknown racial/ethnic categories were not analyzed. Pre-pregnancy BMI levels (normal:
18.5 to <25, overweight: 25 to <30, obese: ≥30) were categorized according to the National
Institutes of Health (National Heart and National Institutes of Health, 1998); underweight
mothers prior to pregnancy were not analyzed due to small sample size. Data were analyzed
using Statistical Analysis System software, version 9.2 (SAS Institute, Inc., Cary, North
Carolina).
Multiple statistical tests investigating the association between micronutrients and phenotype
stratified by effect modifiers including ethnicity and BMI were computed. The OR and 95%




Characteristics of case and control women are found in Table 1. Of the 954 case women,
300 had pregnancies affected by anencephaly and 654 by spina bifida. Pregnancy outcomes
among anencephaly cases were 85 (28%) live births, 142 (47%) terminations, 72 (24%) fetal
deaths, and 1 (<0.01%) unknown outcome. Pregnancy outcomes among spina bifida cases
were 581 (89%) live births, 61 (9%) terminations, and 12 (2%) fetal deaths. Case women
were more likely to be Hispanic (33.4% vs. 22.4%, respectively), less likely to report
education levels above high school degree (50.5% vs. 58.2%), and less likely to be
primigravida (25.1% vs. 29.1%) than control women. Spina bifida cases were more likely
than controls to have maternal age ≤ 30 years at conception (75.2% vs. 70.7%) and more
likely to report BMI in obese range (23.2% vs. 15.4%). Nearly half of participants were non-
users of supplements (46.1%); no difference was observed among case and control women
(47.6% vs. 45.9%). Use of folic acid supplementation did not vary between anencephaly or
spina bifida cases.
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NTD risks were assessed with and without adjustment for potential confounders
(socioeconomic status, maternal smoking, alcohol consumption, age and race/ethnicity) with
little or no effect on adjusted odds ratio. Thus, reported analytical models are those adjusted
for center and energy intake. Using a Bonferroni correction to adjust for multiple
comparisons, the p-value is < 0.05 × 10−3. None of the computed OR had a p-value <0.05 ×
10−3. Being concerned that many of the findings could be due to random variation, we
present findings of all OR in Tables 2 through 4, but only discuss the most significant
findings in the text.
Folic acid supplement use
Results for the association between dietary micronutrient intake and NTD stratified by folic
acid supplement use are presented in Table 2. Among non-users of supplements, statistically
significant results included thiamin intake (4th quartile) with an odds ratio of 0.47 (95% CI:
0.25, 0.91) for anencephaly. Among supplement users, iron (4th quartile) had an odds ratio
of 0.51 (95% CI: 0.28, 0.96). OR for other micronutrients did not show a consistent
protective effect.
Maternal race/ethnicity
In Table 3, adjusted odds ratios are listed for each micronutrient and specific NTD with
stratification by maternal race/ethnicity. Among Hispanic women, odds ratios for
anencephaly for the 3rd and 4th quartiles of folate DFE were 0.28 (95% CI: 0.13, 0.58) and
0.46 (95% CI: 0.23, 0.95), respectively, while odds ratios for the same quartiles of betaine
intake were 0.53 (95% CI: 0.30, 0.97) and 0.42 (95% CI: 0.21, 0.83), respectively. Similarly,
Hispanic women with the highest thiamin intake had an odds ratio of 0.40 (95% CI: 0.18,
0.88) for anencephaly.
No statistically significant odds ratios for micronutrient intake and spina bifida risk were
found for white, non-Hispanic women. Also for Hispanic women, we observed odds ratio of
0.53 (95% CI: 0.31, 0.92), 0.52 (95% CI: 0.31, 0.90), and 0.49 ((95% CI: 0.26, 0.91) for
spina bifida for 2nd, 3rd, and 4th quartile vitamin B6 intake. Similarly, we observed in
Hispanic women decreased spina bifida odds ratio of 0.40 (95% CI: 0.23, 0.70), 0.47 (95%
CI: 0.28, 0.79), and 0.53 (95% CI: 0.31, 0.93) for 2nd, 3rd, and 4th quartile vitamin E intake.
Hispanic women had spina bifida odds ratio of 0.57 (95% CI: 0.34, 0.95) for vitamin C and
0.54 (95% CI: 0.30, 0.96) for niacin, each at the highest quartiles. Among Hispanics, retinol
intake at the 2nd and 4th quartiles had odds ratio of 0.46 (95% CI: 0.29, 0.74) and 0.62 (95%
CI: 0.40, 0.96), respectively. Black, non-Hispanic women had an odds ratio of 0.33 (95%
CI: 0.11, 0.98) for 4th quartile riboflavin intake.
Maternal body mass index
Due to the growing evidence that maternal obesity is associated with increased risk of
having offspring affected by congenital anomalies (Stothard and others, 2009), we examined
associations between dietary micronutrient intake and NTDs when stratified by pre-
pregnancy BMI (Table 4). For anencephaly, women with normal weights had increased odds
ratio of 2.24 (95% CI: 1.26, 3.99) and 2.39 (95% CI: 1.16, 4.91) for 3rd and 4th quartiles of
alanine intake. Normal-weighted women with the highest intake of vitamin A had a reduced
odds ratio of 0.57 (95% CI: 0.33, 0.99) for anencephaly. Overweight women had an odds
ratio of 0.29 (95% CI: 0.10, 0.86) for 4th quartile thiamin intake. Significant associations for
anencephaly in obese women were not found.
No statistically significant odds ratio for spina bifida in women with normal BMIs were
observed for micronutrients. In overweight women, odds ratios for spina bifida for 3rd and
4th quartiles of thiamin were 0.42 (95% CI: 0.24, 0.74) and 0.45 (95% CI: 0.23, 0.89).
Chandler et al. Page 5










Additionally, overweight women with riboflavin intake in the 2nd, 3rd, and 4th quartiles had
odds ratios for spina bifida of 0.45 (95% CI: 0.27, 0.75), 0.51 (95% CI: 0.30, 0.87), and 0.39
(95% CI: 0.20, 0.76), respectively. Similarly, vitamin E intake in 2nd, 3rd, and 4th quartiles
in overweight women had decreased odds ratios of 0.46 (95% CI: 0.28, 0.76), 0.56 (95% CI:
0.33, 0.95), and 0.51 (95% CI: 0.28, 0.95). For obese women, vitamin E at the 3rd and 4th
quartiles had odds ratios of 0.51 (95% CI: 0.29, 0.89) and 0.52 (95% CI: 0.28, 0.95) for
spina bifida.
DISCUSSION
We observed several significant associations between NTDs and maternal dietary
micronutrient intake. Our results suggest maternal diets higher in folate, betaine, thiamin,
iron, and vitamin A may contribute to lowering anencephaly risk among some women. For
spina bifida, diets higher in thiamin, riboflavin, vitamin B6, vitamin C, vitamin E, niacin,
and retinol appear to decrease risk in certain women. Thiamin had associations for both
anencephaly and spina bifida. Interestingly, analyses revealed inverse associations for higher
intakes of alanine related to anencephaly-affected pregnancies in normal-weight women.
Similarities in folic acid supplement use among cases and controls were reported in previous
NBDPS data on folate and NTDs (Mosley and others, 2009). In a larger sample including
two additional years of enrollment, we did not observe any difference in folic acid
supplement use between cases and controls. Current analysis reveals an association between
increased dietary folate intake and decreased risk of anencephaly among Hispanic women,
(Shaw and others, 1995) and perhaps among supplement users and overweight women. The
previous NBDPS report (Mosley and others, 2009) shows similar reduced occurrence of
anencephaly with higher dietary folate. Specifically, for highest quartile of dietary folate
intake, Hispanic women were 54% less likely to have offspring with anencephaly compared
to Hispanic women with lowest dietary folate intake. Similarly, overweight women with
high folate intake were 62% less likely to have offspring with anencephaly when compared
to overweight women with lowest dietary folate intake. In the post-fortification era, these
results suggest additional periconceptional folate intake may be necessary to further prevent
anencephaly. Folate intake did not appear to significantly influence spina bifida risk whether
stratified for folic acid supplementation, race/ethnicity, or BMI.
Recently, researchers are focusing on folate-related micronutrients involved in one-carbon
metabolism including methionine, choline, betaine, thiamin, riboflavin, vitamin B6, and
vitamin B12. Shaw et al. (Shaw and others, 1999) reported decreased NTD risk among
women with increased thiamin intake who did not take periconceptional vitamin
supplements. Our study supports an association between increased thiamin intake and
decreased anencephaly risk among non-users of folic acid supplements, as well as Hispanic
women. Additionally, overweight women with the highest intakes of thiamin were 71% less
likely to have a pregnancy affected by anencephaly and 55% less likely to have a pregnancy
affected by spina bifida. Higher levels of choline (Shaw and others, 2009) and vitamin B12
(Suarez and others, 2003) in maternal serum have been suggested to be protective against
NTDs. Diets high in choline, betaine, methionine, and vitamin B12 have also been reported
to decrease NTD risk (Shaw and others, 2004; Shaw and others, 1997; Suarez and others,
2003). This study did not observe an association between higher choline, methionine, or
vitamin B12 intake and NTD risk. We observed that increased betaine intake was associated
with decreased risk of anencephaly among Hispanics. Black, non-Hispanic women and
overweight women with the highest riboflavin intakes were approximately 67% and 61%,
less likely to have a spina bifida affected pregnancy than women with lowest intakes of
these micronutrients. Factors related to genetics or metabolic activity could explain
differences among subpopulations or this could be due to chance.
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Despite an overall decrease in NTD prevalence in the US, NTD prevalence among Hispanic
women continues to remain higher than other racial/ethnic groups (2009; Canfield and
others, 2005; Canfield and others, 2006; Williams and others, 2005). Participant
demographics in the current study support this finding. Our results suggest increased intake
of several micronutrients related to one-carbon metabolism, including folate, betaine,
thiamin, riboflavin, and vitamin B6 may be associated with decreased occurrence of NTDs
among Hispanics. Additionally, higher intakes of antioxidants vitamin C and E appear to be
associated with decreased likelihood of having a pregnancy affected by spina bifida. In fact,
higher intakes of many micronutrients within this study were associated with decreased risk
of anencephaly or spina bifida among Hispanic women. While the answer may simply be
inadequate nutrition among Hispanic populations due to lower socioeconomic status,
additional explanations include potential existence of an underlying genetic component
affecting the folate-related metabolic pathway or the propensity towards a state of increased
oxidative stress.
Other studies found associations between maternal obesity and occurrence of birth defects
(Gilboa and others, 2010; Rasmussen and others, 2008; Waller and others, 2007; Watkins
and others, 2003). The 2007 NBDPS report on pre-pregnancy obesity noted obese women
were twice as likely to have offspring affected by spina bifida (Waller and others, 2007).
Our data indicate obese women are more likely to have offspring affected with spina bifida.
Higher vitamin E intake among overweight and obese women was associated with decreased
risk of spina bifida by almost half compared to the lowest intake of vitamin E. A 2008
review suggests obesity and obesity-related metabolic alterations result in a state of
oxidative stress similar to diabetes, a known condition leading to increased risk of birth
defects (Reece, 2008). Thus, increased dietary intake of antioxidant-rich foods may decrease
the risk of NTDs particularly among overweight and obese women.
When taking a broader approach than restricting discussion of odds ratio to those excluding
1, i.e. using an a priori threshold of 30% reduction or increase in risk, even more
associations are possible between maternal dietary intake of micronutrients and NTD-risk.
This view supports the need for additional research into these micronutrients contributing
towards reduced NTD occurrence.
Primary limitations include potential for recall bias and small numbers of cases in certain
subgroups. The validity of food questionnaires has been published (Willett and others,
1987), although we cannot discount limitations of this type of dietary assessment. Food
items which are either over- or under-reported could result in false presence or absence of
association of micronutrients with NTDs. Available data on subgroups based on race/
ethnicity or BMI may be too limited to observe potential factors affecting NTD risk within
these populations. The number of black, non-Hispanic case women was only 76,
representing 8% of all NTD cases, while obese women comprised 21.1% of all NTD cases.
Furthermore, small sample sizes limited our ability to stratify analyses by or adjust for
multivitamin supplement use when examining the association between NTD risk and race/
ethnicity or BMI. Lack of daily micronutrient intake from supplements prevented including
these data in calculating the quartiles of intake. Increased numbers in these subgroups could
help unearth important differences among subpopulations. We made 816 comparisons
testing associations between NTDs and maternal micronutrient intake and some may insist
that adjustment is made for multiple comparisons. However, adjustment of P-values for
multiple comparisons remains controversial (Rothman and others, 2008). We did not correct
for multiple comparisons; if we had, the significance level would have been affected. With
816 comparisons, many of the observed results were consistent with random variation. This
trade-off is acceptable in this analysis to identify other micronutrients involved in one-
carbon metabolism or antioxidant activity that might influence NTD risk for future research.
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Additionally, for many statistically significant odds ratios where a lower intake of a
micronutrient (2nd quartile and/or 3rd quartile) appeared protective but not higher levels (3rd
and/or 4th quartiles), speculations regarding biological plausibility are challenging. Our
findings consistent with other studies provide greater confidence in results. Many of the
associations between specific micronutrients, phenotypes, and covariates have been
evaluated for the first time and will require replication within independent populations.
Even with such limitations, the NBDPS has provided the most extensive study base to date
to explore important questions between nutrients and risk of NTDs. Strengths of this study
are large number of cases and amount of detailed dietary information and potential cofactors
examined. This allowed for epidemiologic study of NTDs and dietary intake evaluating
these relationships for potential confounders and by population subgroups. We observed
that, in addition to folate, several micronutrients involved in either one-carbon metabolism
or antioxidant activity may influence NTD risk and these effects might be different in
certain subpopulations. Further investigation should be directed towards determining which
factors are important for certain cohorts of women, particularly based upon their racial/
ethnic background and pre-pregnancy body habitus.
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Table 1









N (%) N (%) N (%) N (%)
Total 954 300 654 6268
Maternal race/ethnicity
    White, non-Hispanic 494 (51.8%) 143 (47.7%) 351 (53.7%) 3748 (59.8%)
    Hispanic 319 (33.4%) 108 (36.0%) 211 (32.3%) 1404 (22.4%)
    Black, non-Hispanic 76 (8.0%) 23 (7.7%) 53 (8.1%) 700 (11.2%)
    Other races 63 (6.6%) 25 (8.3%) 38 (5.8%) 390 (6.2%)
Maternal age at conception
    < 20 years 137 (14.4%) 48 (16.0%) 89 (13.6%) 866 (13.8%)
    20–25 years 265 (27.8%) 68 (22.7%) 197 (30.1%) 1794 (28.6%)
    26–30 years 301 (31.6%) 95 (31.7%) 206 (31.5%) 1774 (28.3%)
    31–35 years 167 (17.5%) 63 (21.0%) 104 (15.9%) 1322 (21.1%)
    36+ years 84 (8.8%) 26 (8.7%) 58 (8.9%) 512 (8.2%)
Maternal education
    0–11 years 200 (21.0%) 69 (23.0%) 131 (20.0%) 1046 (16.7%)
    High school diploma/GED 270 (28.3%) 86 (28.7%) 184 (28.1%) 1542 (24.6%)
    Some college/Technical 274 (28.7%) 73 (24.3%) 201 (30.7%) 1692 (27.0%)
    Bachelor degree 163 (17.1%) 54 (18.0%) 109 (16.7%) 1411 (22.5%)
    Graduate degree 45 (4.7%) 17 (5.7%) 28 (4.3%) 546 (8.7%)
Maternal body mass index, kg/m2
    < 18.5 42 (4.4%) 18 (6.0%) 24 (3.7%) 336 (5.4%)
    18.5 to < 25 442 (46.3%) 151 (50.3%) 291 (44.5%) 3373 (53.8%)
    25 to < 30 214 (22.4%) 64 (21.3%) 150 (22.9%) 1347 (21.5%)
    30+ 201 (21.1%) 49 (16.3%) 152 (23.2%) 966 (15.4%)
Previous Pregnancies
    0 239 (25.1%) 68 (22.7%) 171 (26.2%) 1824 (29.1%)
    1 276 (28.9%) 93 (31.0%) 183 (28.0%) 1847 (29.5%)
    2 190 (19.9%) 53 (17.7%) 137 (21.0%) 1280 (20.4%)
    3+ 249 (26.1%) 86 (28.7%) 163 (24.9%) 1316 (21.0%)
Folic acid supplement use
    No use B3-P1 454 (47.6%) 142 (47.3%) 312 (47.7%) 2874 (45.9%)
    Supplement use B3-P1 477 (50.0%) 151 (50.3%) 326 (49.9%) 3288 (52.5%)
Abbreviations: B3, 3 months before pregnancy; GED, general equivalency diploma; NTD, neural tube defect; P1, 1st month of pregnancy.
Proportions of sums less than 100% can be attributed to missing data.
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Table 2
Association Between Anencephaly or Spina Bifida and Maternal Dietary Micronutrient Intake Stratified by
Periconceptional Supplement Use, National Birth Defects Prevention Study, 1997–2005
Adjusted Odds Ratiosa (95% confidence intervals)














Folate DFE (µg DFE)
    <338.16 referent referent referent referent
    338.16–496.15 0.78 (0.48, 1.26) 0.89 (0.57, 1.39) 0.88 (0.62, 1.25) 0.87 (0.63, 1.21)
    496.16–720.06 0.65 (0.38, 1.10) 0.55 (0.33, 0.93) 0.92 (0.64, 1.32) 0.79 (0.56, 1.13)
    >720.06 0.65 (0.37, 1.16) 0.72 (0.41, 1.26) 0.87 (0.58, 1.30) 0.91 (0.61, 1.35)
Methionine (g)
    <1.10 referent referent referent referent
    1.10–1.43 1.02 (0.60, 1.74) 0.99 (0.60, 1.64) 0.69 (0.47, 1.00) 1.01 (0.72, 1.42)
    1.44–1.87 1.11 (0.62, 1.98) 1.12 (0.64, 1.94) 0.91 (0.62, 1.35) 0.78 (0.52, 1.15)
    >1.87 1.44 (0.74, 2.84) 1.09 (0.54, 2.20) 1.23 (0.78, 1.95) 1.02 (0.63, 1.65)
Cysteine (g)
    <0.66 referent referent referent referent
    0.66–0.86 0.97 (0.59, 1.61) 1.15 (0.70, 1.88) 0.76 (0.52, 1.10) 0.85 (0.60, 1.19)
    0.87–1.15 0.95 (0.55, 1.65) 1.12 (0.66, 1.91) 1.27 (0.87, 1.83) 0.76 (0.52, 1.09)
    >1.15 0.98 (0.52, 1.85) 0.84 (0.44, 1.60) 1.30 (0.84, 2.02) 0.76 (0.49, 1.17)
Choline, Total (mg)
    <190.41 referent referent referent referent
    190.41–254.08 0.96 (0.54, 1.69) 0.95 (0.59, 1.54) 0.67 (0.45, 0.99) 0.95 (0.68, 1.33)
    254.09–343.19 1.31 (0.73, 2.34) 0.88 (0.50, 1.53) 0.87 (0.58, 1.30) 0.93 (0.63, 1.37)
    >343.19 1.54 (0.77, 3.07) 0.86 (0.42, 1.77) 1.38 (0.87, 2.20) 0.83 (0.50, 1.38)
Betaine (mg)
    <46.60 referent referent referent referent
    46.60–75.28 0.83 (0.53, 1.30) 1.03 (0.64, 1.64) 0.77 (0.56, 1.07) 1.01 (0.73, 1.40)
    75.29–123.55 0.68 (0.41, 1.11) 1.17 (0.73, 1.88) 0.79 (0.56, 1.11) 0.99 (0.71. 1.39)
    >123.55 0.64 (0.38, 1.09) 0.98 (0.58, 1.66) 0.85 (0.60, 1.21) 0.94 (0.65, 1.35)
Thiamin (mg)
    <0.89 referent referent referent referent
    0.89–1.21 0.57 (0.33, 0.95) 0.79 (0.49, 1.25) 0.80 (0.56, 1.14) 0.75 (0.54, 1.05)
    1.22–1.67 0.74 (0.44, 1.25) 0.69 (0.41, 1.16) 0.84 (0.58, 1.23) 0.79 (0.54, 1.14)
    >1.67 0.47 (0.25, 0.91) 0.52 (0.27, 1.02) 0.77 (0.49, 1.21) 0.80 (0.51, 1.26)
Riboflavin (mg)
    <1.39 referent referent referent referent
    1.39–1.91 0.69 (0.42, 1.13) 0.90 (0.57, 1.44) 0.73 (0.51, 1.04) 0.70 (0.50, 0.97)
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Adjusted Odds Ratiosa (95% confidence intervals)













    1.92–2.62 0.69 (0.41, 1.18) 0.76 (0.45, 1.29) 0.96 (0.67, 1.38) 0.63 (0.44, 0.91)
    >2.62 0.59 (0.32, 1.11) 0.79 (0.43, 1.47) 0.86 (0.55, 1.33) 0.68 (0.45, 1.05)
Vitamin B6 (mg)
    <1.39 referent referent referent referent
    1.39–1.91 1.29 (0.75, 2.23) 0.97 (0.60, 1.7) 0.86 (0.60, 1.23) 0.86 (0.61, 1.21)
    1.92–2.67 1.40 (0.79, 2.49) 0.95 (0.55, 1.8) 0.81 (0.55, 1.20) 0.97 (0.66, 1.42)
    >2.67 1.16 (0.58, 2.33) 0.80 (0.41, 1.7) 0.91 (0.58, 1.44) 1.09 (0.69, 1.73)
Vitamin B12 (µg)
    < 3.49 referent referent referent referent
    3.49–5.09 1.10 (0.67, 1.83) 0.90 (0.57, 1.42) 0.92 (0.64, 1.31) 0.79 (0.56, 1.09)
    5.10–7.40 0.92 (0.53, 1.59) 0.71 (0.42, 1.20) 1.03 (0.71, 1.49) 0.80 (0.56, 1.14)
    >7.40 0.98 (0.54, 1.78) 0.77 (0.42, 1.40) 1.13 (0.75, 1.69) 0.90 (0.60, 1.36)
Antioxidants
Vitamin C (mg)
    <59.67 referent referent referent referent
    59.67–101.90 0.93 (0.54, 1.59) 1.04 (0.68, 1.59) 0.77 (0.54, 1.08) 0.78 (0.56, 1.07)
    101.91–154.90 1.58 (0.96, 2.61) 0.85 (0.53, 1.37) 0.71 (0.50, 1.02) 1.03 (0.75, 1.42)
    >154.90 1.09 (0.62, 1.91) 0.58 (0.32, 1.05) 0.82 (0.57, 1.19) 0.87 (0.59, 1.28)
Vitamin E (mg)
    <2.86 referent referent referent referent
    2.86–4.13 1.24 (0.72, 2.12) 0.69 (0.44, 1.07) 0.87 (0.62, 1.24) 0.69 (0.50, 0.97)
    4.14–6.09 1.52 (0.88, 2.63) 0.48 (0.28, 0.83) 0.67 (0.45, 0.99) 0.86 (0.61, 1.21)
    >6.09 1.36 (0.73, 2.56) 0.73 (0.42, 1.26) 1.01 (0.66, 1.52) 0.67 (0.44, 1.00)
Others
Alanine (g)
    <2.25 referent referent referent referent
    2.25–2.94 0.82 (0.46, 1.47) 1.19 (0.72, 1.95) 0.60 (0.40, 0.89) 1.03 (0.74, 1.45)
    2.95–3.85 1.49 (0.84, 2.64) 1.19 (0.67, 2.08) 1.05 (0.71, 1.54) 0.77 (0.52, 1.15)
    >3.85 1.79 (0.90, 3.56) 1.15 (0.56, 2.37) 1.32 (0.83, 2.11) 0.96 (0.59, 1.57)
Niacin (mg)
    <13.45 referent referent referent referent
    13.45–17.77 1.04 (0.62, 1.73) 0.96 (0.59, 1.56) 0.91 (0.64, 1.29) 0.93 (0.66, 1.31)
    17.78–23.65 1.06 (0.61, 1.83) 1.05 (0.61, 1.79) 0.91 (0.62, 1.33) 1.00 (0.68, 1.45)
    >23.65 0.84 (0.43, 1.63) 0.70 (0.36, 1.39) 0.88 (0.56, 1.38) 0.88 (0.55, 1.39)
Iron (mg)
    <8.62 referent referent referent referent
    8.62–12.50 0.80 (0.48, 1.36) 0.77 (0.49, 1.22) 0.90 (0.63, 1.29) 0.90 (0.64, 1.25)
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Adjusted Odds Ratiosa (95% confidence intervals)













    12.51–17.70 0.81 (0.47, 1.39) 0.59 (0.35, 1.00) 0.82 (0.55, 1.20) 0.74 (0.51, 1.08)
    >17.70 0.68 (0.36, 1.29) 0.51 (0.28, 0.96) 0.96 (0.62, 1.47) 1.08 (0.71, 1.63)
Zinc (mg)
    <7.99 referent referent referent referent
    7.99–10.71 0.82 (0.47, 1.41) 1.64 (0.98, 2.75) 0.66 (0.45, 0.97) 0.98 (0.70, 1.38)
    10.72–14.30 0.96 (0.54, 1.70) 1.51 (0.83, 2.74) 0.82 (0.55, 1.21) 0.88 (0.59, 1.32)
    >14.30 0.77 (0.38, 1.56) 1.57 (0.76, 3.23) 0.96 (0.59, 1.54) 1.05 (0.65, 1.70)
Retinol (µg)
    <218.60 referent referent referent referent
    218.60–348.59 0.71 (0.44, 1.15) 0.96 (0.61, 1.51) 0.82 (0.58, 1.16) 0.91 (0.66, 1.25)
    348.60–535.10 0.62 (0.37, 1.04) 0.86 (0.53, 1.38) 0.96 (0.68, 1.35) 0.74 (0.52, 1.04)
    >535.10 0.74 (0.44, 1.23) 0.69 (0.40, 1.21) 0.94 (0.65, 1.36) 0.88 (0.61, 1.29)
Vitamin A, RAE (µg RAE)
    <390.88 referent referent referent referent
    390.88–592.60 0.75 (0.46, 1.25) 0.70 (0.44, 1.12) 0.93 (0.66, 1.30) 0.95 (0.69, 1.30)
    592.61–858.76 1.07 (0.65, 1.75) 0.76 (0.47, 1.22) 0.94 (0.66, 1.35) 0.69 (0.48, 0.98)
    >858.76 0.85 (0.49, 1.48) 0.71 (0.40, 1.23) 1.00 (0.68, 1.46) 0.81 (0.55, 1.20)
Abbreviations: DFE, dietary folate equivalent; RAE, retinol activity equivalent.
a
Adjusted model includes center and log-transformed energy intake.
b
Cases only. For controls: Non-users of supplements (n=2874); Supplement users (n=3288).
c
Quartiles based on daily nutrient intake of control mothers.
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